{"id":"NCT00294515","sponsor":"Hoffmann-La Roche","briefTitle":"IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Efficacy and Safety of up to 100 Days of Valganciclovir Versus up to 200 Days of Valganciclovir for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Kidney Allograft Recipients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03-31","primaryCompletion":"2008-08-31","completion":"2009-08-31","firstPosted":"2006-02-22","resultsPosted":"2010-07-05","lastUpdate":"2018-03-29"},"enrollment":326,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cytomegalovirus Infections"],"interventions":[{"type":"DRUG","name":"Valganciclovir","otherNames":["Valcyte"]},{"type":"DRUG","name":"Valganciclovir","otherNames":["Valcyte"]}],"arms":[{"label":"Valganciclovir up to 100 days","type":"EXPERIMENTAL"},{"label":"Valganciclovir up to 200 days","type":"ACTIVE_COMPARATOR"}],"summary":"This study will determine the relative efficacy and safety of up to 100 days Valcyte prophylaxis relative to up to 200 days Valcyte prophylaxis when given for the prevention of CMV disease in high-risk (D+/R-) kidney allograft recipients. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.","primaryOutcome":{"measure":"Percentage of Patients Who Developed Cytomegalovirus (CMV) Disease up to Month 12 Post-transplant","timeFrame":"12 months post-transplant","effectByArm":[{"arm":"Valganciclovir up to 100 Days","deltaMin":43.6,"sd":null},{"arm":"Valganciclovir up to 200 Days","deltaMin":23.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<=0.0002"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":80,"countries":["United States","Australia","Belgium","Brazil","Canada","France","Germany","Italy","New Zealand","Poland","Romania","Spain","United Kingdom"]},"refs":{"pmids":["39807668","38700045","20353469"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":94,"n":164},"commonTop":["Leukopenia","Diarrhoea","Oedema Peripheral","Anaemia","Urinary Tract Infection"]}}